Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metlife (MET) EBIT (2016 - 2025)

Metlife (MET) has 17 years of EBIT data on record, last reported at $186.0 million in Q3 2025.

  • For Q3 2025, EBIT fell 95.39% year-over-year to $186.0 million; the TTM value through Sep 2025 reached -$8.1 billion, down 136.76%, while the annual FY2024 figure was $217.0 million, 99.03% down from the prior year.
  • EBIT reached $186.0 million in Q3 2025 per MET's latest filing, down from $5.7 billion in the prior quarter.
  • Across five years, EBIT topped out at $7.2 billion in Q4 2023 and bottomed at -$23.5 billion in Q2 2023.
  • Average EBIT over 5 years is -$1.1 billion, with a median of $3.4 billion recorded in 2024.
  • The widest YoY moves for EBIT: up 219.02% in 2022, down 169762.5% in 2022.
  • A 5-year view of EBIT shows it stood at $8.0 million in 2021, then tumbled by 169762.5% to -$13.6 billion in 2022, then surged by 153.41% to $7.2 billion in 2023, then plummeted by 53.19% to $3.4 billion in 2024, then tumbled by 94.52% to $186.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $186.0 million in Q3 2025, $5.7 billion in Q2 2025, and -$17.3 billion in Q1 2025.